Muhammad Shehzad Afzal

Statistics

Publications

Citations

174

H-Index

Active since

2004

Affiliations

Columbia University Irving Medical Center(Current)

Presbyterian Hospital

University of Edinburgh

University of Virginia

Technion – Israel Institute of Technology

Muhammad Shehzad Afzal is an author at Columbia University Irving Medical Center specializing in infectious diseases, cardiovascular epidemiology, and medical microbiology.

Publications per year

2004–2021

Publications

99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection.

Muhammad Saeed Akhtar, Javed Iqbal, Muhammad Aleem Khan et al. · PubMed · 2004 · 86 citations

Life Sciences, Infectious Diseases, Microbiology +14

Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World

Cole B. Hirschfeld, Leslee J. Shaw, Michelle A. Williams et al. · JACC. Cardiovascular imaging · 2021 · 39 citations · Full text

Medicine, Cardiology, Preventive Medicine +14

Potential risk of cross-infection by tourniquets: a need for effective control practices in pakistan.

Zara Mehmood, Syed Muhammad Mubeen, Muhammad Shehzad Afzal et al. · PubMed · 2014 · 20 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Potential Risk of Cross-Infection by Tourniquets: A Need for Effective Control Practices in Pakistan

Zara Mehmood, Syed Muhammad Mubeen, Muhammad Shehzad Afzal et al. · 2014 · 16 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +12

Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

Takashi Kudo, Ryan Lahey, Cole B. Hirschfeld et al. · JACC Asia · 2021 · 13 citations · Full text

Medicine, Cardiology, Health Sciences +12

1–5 of 5